Eikon Therapeutics

Eikon Therapeutics company information, Employees & Contact Information

Eikon Therapeutics is a new biopharmaceutical company employing revolutionary technology at the interface of biology, engineering and chemistry to discover novel treatments for life-threatening diseases. Eikon’s discovery platform is built on groundbreaking innovations from its founders (Nobel Prize, 2014), culminating in the creation of microscopes which enable real time, molecular-resolution measurements of protein movement in living cells. By directly measuring the effects of chemical compounds on the behavior of protein molecules in a live cellular environment, Eikon’s landmark assays facilitate the highly sensitive identification of compound-protein interactions that could not be identified through traditional assays, thereby unlocking otherwise intractable classes of proteins as drug targets. Furthermore, the ability to directly visualize protein mechanisms in disease coupled with the extraordinarily high-powered high-content data sets generated by Eikon’s drug-screening technology enable an unprecedented opportunity to quantitatively explore novel biology in the living cell. These insights facilitate creation and application of data-driven hypotheses to the discovery of life-saving therapies. Eikon is seeking adventurous, passionate and creative team members eager to apply their talents to empower interdisciplinary scientific exploration, inaugurate a radical drug-discovery paradigm, and ultimately create novel medicines. To learn more about open positions, please visit: https://www.eikontx.com/join-us/#open-positions

Company Details

Employees
394
Founded
-
Address
3929 Point Eden Way, Hayward,ca 94545,united States
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
Hayward, CA
Looking for a particular Eikon Therapeutics employee's phone or email?

Eikon Therapeutics Questions

News

Eikon Therapeutics Raises $350 Million in Series D Funding to Advance Oncology Pipeline - Pharmaceutical Executive

Eikon Therapeutics Raises $350 Million in Series D Funding to Advance Oncology Pipeline Pharmaceutical Executive

Eikon Therapeutics Secures $350.7 Million Series D to Advance Clinical-Stage Programs and Future Pipeline - Business Wire

Eikon Therapeutics Secures $350.7 Million Series D to Advance Clinical-Stage Programs and Future Pipeline Business Wire

Eikon Therapeutics Announces Appointment of Michael Klobuchar as Chief Operating Officer - Yahoo Finance

Eikon Therapeutics Announces Appointment of Michael Klobuchar as Chief Operating Officer Yahoo Finance

Editorial: Pharmacokinetics modeling in the Artificial Intelligence Era - Frontiers

Editorial: Pharmacokinetics modeling in the Artificial Intelligence Era Frontiers

Eikon Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference - FinancialContent

Eikon Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference FinancialContent

Eikon Therapeutics Announces Multiple Abstracts to be Presented at the American Society of Clinical Oncology (ASCO) Annual Meeting - The AI Journal

Eikon Therapeutics Announces Multiple Abstracts to be Presented at the American Society of Clinical Oncology (ASCO) Annual Meeting The AI Journal

Eikon Therapeutics Announces Nature Methods Publication Highlighting its Pioneering Oblique Line Scan Technology - FinancialContent

Eikon Therapeutics Announces Nature Methods Publication Highlighting its Pioneering Oblique Line Scan Technology FinancialContent

Eikon Therapeutics Acquires Global Rights to Clinical-Stage Assets and Announces Emerging Drug Development Pipeline - Business Wire

Eikon Therapeutics Acquires Global Rights to Clinical-Stage Assets and Announces Emerging Drug Development Pipeline Business Wire

Eikon Therapeutics Builds Leading Clinical Development Organization with Appointment of Senior Team with Extensive Industry Expertise - Business Wire

Eikon Therapeutics Builds Leading Clinical Development Organization with Appointment of Senior Team with Extensive Industry Expertise Business Wire

Eikon Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference - FinancialContent

Eikon Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference FinancialContent

Top Eikon Therapeutics Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant